White Paper

What Is The Cost Of Not Doing MES?

Bioprocess

“If you need to do an ROI study, then perhaps MES is not for you ...!” goes a provocative comment from a consultant when positioning to management the benefits of Manufacturing Execution Systems (MES). In this age of digitization, many pharma and biotech companies still struggle to gain senior level buy-in for investments in manufacturing IT. Whilst corporate IT initiatives such as Enterprise Resource Planning (ERP) are well understood and seen as ‘nobrainers’, not believing in a Return On Investment (ROI) for manufacturing solutions is a major reason why companies still struggle to eliminate paper GxP records and modernize systems.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Werum IT Solutions America, Inc.